Nulojix is biologic therapy that is indicated for treating
- transplant rejection in adults who have received a kidney transplant
Nulojix is a biologic infusion therapy that helps prevent transplant rejection in adults who have received a kidney transplant.
Nulojix (belatacept) is a selective T-cell (lymphocyte, a type of white blood cell) costimulation blocker.
It binds to CD80 and CD86 on antigen-presenting cells, thereby blocking CD28 mediated costimulation of T-lymphocytes.
Nulojix treatments are given the day of your kidney transplant and then at four days, two weeks, four weeks, eight weeks, and twelve weeks after the transplant, with each infusion lasting roughly 30 minutes.
How Nulojix works to prevent organ rejection
Patients choose Red Bank Infusion Center
to have their Nulojix therapy because
- of our flexible, worry-free scheduling, with evening and weekend appointments available
- our all-private infusion suites, with the latest COVID safety standards in place for your protection
- equipped with medical-grade, leather recliners, with chairs and amenities for your guests
- including large, flat screen TVs, free WiFi and entertainment channels for your viewing pleasure
- and our friendly, helpful clinical staff providing personalized service
Want to move to
Red Bank Infusion Center?
We make it simple and convenient for you to start your infusion care with us.
